STOCK TITAN

VICR (NASDAQ) Form 144: Director/entity lists 20,000-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Company VICR (issuer line) furnished a Form 144 notice relating to proposed sales of common stock. The filing lists a proposed sale quantity of 20,000 shares with a date shown as 06/26/2026. The excerpt also lists multiple recent 10b5-1 sales by Patrizio Vinciarelli and institution names with dated sale lines and per-line amounts.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144/Form 144 resale notice and listed 10b5-1 transactions.

The filing is a procedural resale notice under Rule 144 that lists a proposed sale of 20,000 shares dated 06/26/2026. It also documents numerous dated 10b5-1 sale entries showing identical share-line quantities and monetary amounts.

Transaction timing and cash recipients are not specified beyond the dated sale lines; subsequent filings or trade reports will show execution details. Compliance checks should verify volume limitations and any holding-period or manner-of-sale conditions in underlying documents.

Proposed sale 20,000 shares listed with date 06/26/2026 on the issuer line
10b5-1 sale example 20,000 shares 10b5-1 sale on 06/25/2026 with amount 6611104.00
10b5-1 sale example 20,000 shares 10b5-1 sale on 06/24/2026 with amount 6528724.00
Larger prior 10b5-1 sale 50,000 shares 10b5-1 sale on 04/15/2026 with amount 9660511.00
Institutional sale lines 3,500 shares Brigham and Women's Hospital sale on 05/14/2026 with amount 1043623.00
10b5-1 regulatory
"Multiple lines labeled "10b5-1 Sales for PATRIZIO VINCIARELLI""
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Header and issuer lines indicating a resale notice"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares market
"Line: "Founders Shares | Issuer | 20000 | 11/10/1981""
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the VICR Form 144 submission report?

It reports a proposed sale of 20,000 shares with a filing line dated 06/26/2026. The excerpt also lists multiple dated 10b5-1 sale entries and institutional sale lines for context.

Who is shown as the seller in the Form 144 excerpt for VICR?

The excerpt lists Patrizio Vinciarelli multiple times (10b5-1 sales) and institutional entries (e.g., Brigham and Women's Hospital, Lahey Hospital & Medical Center) on specific dated sale lines.

Do the lines show executed sales or proposed sales?

The filing includes a proposed sale line of 20,000 shares dated 06/26/2026 and separate dated entries labeled as 10b5-1 Sales, which reflect executed-sale lines in the excerpt.

Are proceeds or prices shown in the VICR excerpt?

Yes; the excerpt shows numeric amounts alongside sale lines (for example, 06/25/2026 line with 20,000 and 6611104.00), presented as amounts in the provided lines.

Does this Form 144 indicate any securities other than common stock?

The excerpt references Common shares and a line labeled Founders Shares dated 11/10/1981; no other security classes are shown in the provided content.